Variant report
Variant | esv17576 |
---|---|
Chromosome Location | chr20:53289505-53294132 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:11)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:11 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:53290085..53292614-chr20:53295758..53297521,2 | MCF-7 | breast: | |
2 | chr20:52823364..52826013-chr20:53290303..53292148,2 | MCF-7 | breast: | |
3 | chr20:53291637..53293579-chr3:170973447..170976277,2 | MCF-7 | breast: | |
4 | chr17:75007000..75007794-chr20:53289529..53290339,2 | MCF-7 | breast: | |
5 | chr20:53291044..53293305-chr20:53298818..53301470,2 | MCF-7 | breast: | |
6 | chr20:53293305..53299094-chr20:53306694..53312269,5 | MCF-7 | breast: | |
7 | chr20:53293528..53294358-chr3:64499023..64499548,2 | MCF-7 | breast: | |
8 | chr2:47214206..47214770-chr20:53290236..53290902,2 | MCF-7 | breast: | |
9 | chr1:114889055..114889767-chr20:53293774..53294462,2 | MCF-7 | breast: | |
10 | chr20:53290237..53291789-chr3:64522620..64525418,2 | MCF-7 | breast: | |
11 | chr16:70414219..70416297-chr20:53291360..53294038,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000101132 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574696955 | chr20:53289505-53289506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376150992 | chr20:53289534-53289535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs79238680 | chr20:53289557-53289558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs386815255 | chr20:53289597-53289598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2870347 | chr20:53289598-53289599 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs117894113 | chr20:53289614-53289615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562936676 | chr20:53289615-53289616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368071284 | chr20:53289626-53289627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114485195 | chr20:53289630-53289631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2870348 | chr20:53289631-53289632 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs2870349 | chr20:53289643-53289644 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs529920902 | chr20:53289664-53289665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546856129 | chr20:53289665-53289666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566544037 | chr20:53289704-53289705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538753031 | chr20:53289709-53289710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551968985 | chr20:53289746-53289747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566557979 | chr20:53289763-53289764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs55924953 | chr20:53289798-53289799 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs537420151 | chr20:53289812-53289813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554852539 | chr20:53289830-53289831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185393364 | chr20:53289832-53289833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs75883969 | chr20:53289842-53289843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554372824 | chr20:53289843-53289844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs74500173 | chr20:53289851-53289852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs202247276 | chr20:53289852-53289853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77056791 | chr20:53289853-53289854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577353242 | chr20:53289855-53289856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs568983680 | chr20:53289917-53289918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546295781 | chr20:53289954-53289955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549322035 | chr20:53289956-53289957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190050957 | chr20:53289961-53289962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs1569730 | chr20:53289977-53289978 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs542201714 | chr20:53289990-53289991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540303351 | chr20:53289994-53289995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs564980192 | chr20:53289997-53289998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562051017 | chr20:53290002-53290003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376699642 | chr20:53290039-53290040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1013661 | chr20:53290058-53290059 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs371806663 | chr20:53290061-53290062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540133273 | chr20:53290065-53290066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560328825 | chr20:53290086-53290087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532174092 | chr20:53290157-53290158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552270454 | chr20:53290196-53290197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557862663 | chr20:53290208-53290209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs11907565 | chr20:53290250-53290251 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs181416162 | chr20:53290257-53290258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs200006430 | chr20:53290268-53290269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567697138 | chr20:53290286-53290287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534258417 | chr20:53290288-53290289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554138412 | chr20:53290327-53290328 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 21693616 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
colon cancer | 17210682 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 21264507 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastric cancer | 17167181 | CNVD |
Myeloproliferative neoplasm | 19047681 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Gastric cancer | 20585902 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Cancer | 21129771 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Lung cancer | 16740712 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16620391 | CNVD |
Okamoto syndrome | 17623483 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Cervical cancer | 16585170 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20459607 | CNVD |
Gastric cancer | 18160780 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Melanoma | 17363583 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:53285600-53290000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
2 | chr20:53290000-53290400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr20:53290200-53290600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr20:53290600-53296800 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |